Direct-to-consumer personal genomic testing: A case study and practical recommendations for "genomic counseling"

Journal of Genetic Counseling

Volumn 21, Issue 3, 2012, Pages 402-412

  Sturm, Amy C ^a   Manickam, Kandamurugu ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

Direct to consumer genetic testing; Family history; Genomic counseling; Personal genomics; Risk assessment

Indexed keywords

ARTICLE; CASE REPORT; CONSUMER; FEMALE; GENETIC COUNSELING; GENETIC SCREENING; GENOMICS; HUMAN; MALE; MIDDLE AGED; PEDIGREE; SINGLE NUCLEOTIDE POLYMORPHISM;

CONSUMER PARTICIPATION; FEMALE; GENETIC COUNSELING; GENETIC TESTING; GENOMICS; HUMANS; MALE; MIDDLE AGED; PEDIGREE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84863616525     PISSN: 10597700     EISSN: 15733599     Source Type: Journal    
DOI: 10.1007/s10897-012-9489-7     Document Type: Article

References (40)

1. Abnet, C. C., Freedman, N. D., Hu, N., Wang, Z., Yu, K., Shu, X. O., et al. (2010). A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nature Genetics, 42(9), 764-767.
2. Alexander, J., & Kowdley, K. V. (2009). HFE-associated hereditary hemochromatosis. Genetics in Medicine, 11(5), 307-313.
3. Bloss, C. S., Schork, N. J., & Topol, E. J. (2011). Effect of direct-toconsumer genomewide profiling to assess disease risk. The New England Journal of Medicine, 364(6), 524-534.
4. Borry, P., Cornel, M. C., & Howard, H. C. (2010). Where are you going, where have you been: a recent history of the direct-toconsumer genetic testing market. Journal of Community Genetics, 1(3), 101-106.
5. Bowen, D. J., Battuello, K. M., & Raats, M. (2005). Marketing genetic tests: empowerment or snake oil? Health Education & Behavior, 32(5), 676-685. (Pubitemid 41426748)
6. Cameron, L. D., Sherman, K. A., Marteau, T. M., & Brown, P. M. (2009). Impact of genetic risk information and type of disease on perceived risk, anticipated affect, and expected consequences of genetic tests. Health Psychology, 28(3), 307-316.
7. Chao, S., Roberts, J. S., Marteau, T. M., Silliman, R., Cupples, L. A., & Green, R. C. (2008). Health behavior changes after genetic risk assessment for Alzheimer disease: the REVEAL study. Alzheimer Disease and Associated Disorders, 22(1), 94-97. (Pubitemid 351651404)
8. Dhillon, P. K., Farrow, D. C., Vaughan, T. L., Chow, W. H., Risch, H. A., Gammon, M. D., et al. (2001). Family history of cancer and risk of esophageal and gastric cancers in the United States. International Journal of Cancer, 93(1), 148-152. (Pubitemid 32544602)
9. DTC Genetic Testing Companies Compiled by the Genetics and Public Policy Center. (2011). Retrieved September 2, 2011, from http://www.dnapolicy.org/ resources/DTCTableAug2011Alphabydisease.pdf.
10. Foster, M. W., Mulvihill, J. J., & Sharp, R. R. (2009). Evaluating the utility of personal genomic information. Genetics in Medicine, 11(8), 570-574.
11. Gollust, S. E., Hull, S. C., & Wilfond, B. S. (2002). Limitations of direct-to-consumer advertising for clinical genetic testing. Journal of the American Medical Association, 288(14), 1762-1767.
12. Gollust, S. E., Gordon, E. S., Zayac, C., Griffin, G., Christman, M. F., Pyeritz, R. E., et al. (2012). Motivations and perceptions of early adopters of personalized genomics: perspectives from research participants. Public Health Genomics, 15, 22-30.
13. Green, R. C., Roberts, J. S., Cupples, L. A., Relkin, N. R., Whitehouse, P. J., Brown, T., et al. (2009). Disclosure of APOE genotype for risk of Alzheimer's disease. The New England Journal of Medicine, 361(3), 245-254.
14. Gulcher, J., & Stefansson, K. (2010). Genetic risk information for common diseases may indeed be already useful for prevention and early detection. European Journal of Clinical Investigation, 40(1), 56-63.
15. Guttmacher, A. E., Porteous, M. E., & McInerney, J. D. (2007). Educating health-care professionals about genetics and genomics. Nature Reviews Genetics, 8(2), 151-157. (Pubitemid 46122843)
16. Hamajima, N., Atsuta, Y., Goto, Y., & Ito, H. (2004). A pilot study on genotype announcement to induce smoking cessation by Japanese smokers. Asian Pacific Journal of Cancer Prevention, 5(4), 409-413.
17. Hamajima, N., Suzuki, K., Ito, Y., & Kondo, T. (2006). Genotype announcement to Japanese smokers who attended a health checkup examination. Journal of Epidemiology, 16(1), 45-47. (Pubitemid 43055687)
18. Ito, H., Matsuo, K., Wakai, K., Saito, T., Kumimoto, H., Okuma, K., et al. (2006). An intervention study of smoking cessation with feedback on genetic cancer susceptibility in Japan. Preventive Medicine, 42(2), 102-108. (Pubitemid 43207415)
19. Janssens, A. C., Wilde, A. A., & van Langen, I. M. (2011). The sense and nonsense of direct-to-consumer genetic testing for cardiovascular disease. Netherlands Heart Journal, 19(2), 85-88.
20. Lagergren, J., Ye, W., Lindgren, A., & Nyren, O. (2000). Heredity and risk of cancer of the esophagus and gastric cardia. Cancer Epidemiology, Biomarkers & Prevention, 9(7), 757-760. (Pubitemid 30482709)
21. Lerman, C., Gold, K., Audrain, J., Lin, T. H., Boyd, N. R., Orleans, C. T., et al. (1997). Incorporating biomarkers of exposure and genetic susceptibility into smoking cessation treatment: effects on smoking-related cognitions, emotions, and behavior change. Health Psychology, 16(1), 87-99. (Pubitemid 127465956)
22. McBride, C. M., Bepler, G., Lipkus, I. M., Lyna, P., Samsa, G., Albright, J., et al. (2002). Incorporating genetic susceptibility feedback into a smoking cessation program for African-American smokers with low income. Cancer Epidemiology, Biomarkers & Prevention, 11(6), 521-528. (Pubitemid 34615158)
23. McBride, C. M., Alford, S. H., Reid, R. J., Larson, E. B., Baxevanis, A. D., & Brody, L. C. (2008). Putting science over supposition in the arena of personalized genomics. Nature Genetics, 40(8), 939-942.
24. McBride, C. M., Alford, S. H., Reid, R. J., Larson, E. B., Baxevanis, A. D., & Brody, L. C. (2009). Characteristics of users of online personalized genomic risk assessments: implications for physician-patient interactions. Genetics in Medicine, 11(8), 582-587.
25. McBride, C. M., Koehly, L. M., Sanderson, S. C., & Kaphingst, K. A. (2010). The behavioral response to personalized genetic information: will genetic risk profiles motivate individuals and families to choose more healthful behaviors? Annual Review of Public Health, 31, 89-103.
26. McCarthy, M. I., Abecasis, G. R., Cardon, L. R., Goldstein, D. B., Little, J., Ioannidis, J. P., et al. (2008). Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nature Reviews Genetics, 9(5), 356-369. (Pubitemid 351556063)
27. Mihaescu, R., van Hoek, M., Sijbrands, E. J., Uitterlinden, A. G., Witteman, J. C., Hofman, A., et al. (2009). Evaluation of risk prediction updates from commercial genome-wide scans. Genetics in Medicine, 11(8), 588-594.
28. Nelson, E. A., & McGuire, A. L. (2010). The need for medical education reform: genomics and the changing nature of health information. Genome Medicine, 2(3), 18.
29. Ng, P. C., Murray, S. S., Levy, S., & Venter, J. C. (2009). An agenda for personalized medicine. Nature, 461(7265), 724-726.
30. O'Daniel, J. M. (2010). The prospect of genome-guided preventive medicine: a need and opportunity for genetic counselors. Journal of Genetic Counseling, 19(4), 315-327.
31. Ransohoff, D. F., & Khoury, M. J. (2010). Personal genomics: information can be harmful. European Journal of Clinical Investigation, 40(1), 64-68.
32. Scheuner, M. T. (2003). Genetic evaluation for coronary artery disease. Genetics in Medicine, 5(4), 269-285. (Pubitemid 36998685)
33. Scheuner, M. T., Whitworth, W. C., McGruder, H., Yoon, P. W., & Khoury, M. J. (2006). Expanding the definition of a positive family history for early-onset coronary heart disease. Genetics in Medicine, 8(8), 491-501.
34. Scheuner, M. T., Sieverding, P., & Shekelle, P. G. (2008). Delivery of genomic medicine for common chronic adult diseases: a systematic review. Journal of the American Medical Association, 299(11), 1320-1334. (Pubitemid 351439078)
35. Soskolne, C. L., & Sieswerda, L. E. (2010). Cancer risk associated with pulp and paper mills: a review of occupational and community epidemiology. Chronic Diseases in Canada, 29(Suppl 2), 86-100.
36. Stack, C. B., Gharani, N., Gordon, E. S., Schmidlen, T., Christman, M. F., & Keller, M. A. (2011). Genetic risk estimation in the Coriell Personalized Medicine Collaborative. Genetics in Medicine, 13(2), 131-139.
37. Swan, M. (2010). Multigenic condition risk assessment in direct-toconsumer genomic services. Genetics in Medicine, 12(5), 279-288.
38. Wang, L. D., Zhou, F. Y., Li, X. M., Sun, L. D., Song, X., Jin, Y., et al. (2010). Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54. Nature Genetics, 42(9), 759-763.
39. Watkins, S., Thorburn, D., Joshi, N., Neilson, M., Joyce, T., Spooner, R., et al. (2008). The biochemical and clinical penetrance of individuals diagnosed with genetic haemochromatosis by predictive genetic testing. European Journal of Gastroenterology and Hepatology, 20(5), 379-383. (Pubitemid 351533873)
40. Yang, Q., Flanders, W. D., Moonesinghe, R., Ioannidis, J. P., Guessous, I., & Khoury, M. J. (2009). Using lifetime risk estimates in personal genomic profiles: estimation of uncertainty. American Journal of Human Genetics, 85(6), 786-800.